Search

everythinglearnresearchcommunity

for

Search:↓

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

New methods to improve the healing abilities of mesenchymal stem cells for disease treatment are promising but need more research.

Insulin resistance is significantly linked to a higher risk of depression in women with PCOS.

Microneedle arrays with nanotechnology show promise for painless drug delivery through the skin but need more research on safety and effectiveness.

Nonablative radiofrequency treatments, especially microneedle and fractional types, can improve acne scars by 25%–75% after 3-4 sessions, with full results in 3 months and some side effects.

Certain eye surgery complications can be managed effectively, especially in patients who have used specific prostate medications.

Testosterone replacement therapy can prevent men from fathering children and should not be used by those wanting to stay fertile.

Adrenal disorders can cause lasting brain and behavior issues in children.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Intravaginal testosterone cream improves sexual satisfaction and reduces vaginal discomfort in postmenopausal women on breast cancer treatment without affecting hormone levels.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.

Bariatric surgery may help severely obese teenagers but has risks and requires careful patient selection and long-term care.

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

Metformin should be used for PCOS mainly in those with glucose intolerance, and has limited benefits for infertility or hirsutism.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

Platelet-Rich Plasma (PRP) shows promise for treating various skin conditions, but more research is needed to standardize its use.

Sex hormones affect brain injury differently in males and females.

Certain leukemia drugs can cause severe skin reactions that may require stopping treatment.

Neuroactive steroids could become safe, effective treatments with more understanding of their complex brain actions and metabolism.

Progesterone and related compounds may help control seizures linked to the menstrual cycle but have limitations that need addressing.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

With careful management, people with congenital adrenal hyperplasia can have successful pregnancies and become parents.

Topical tofacitinib may grow hair better than minoxidil by increasing VEGF and reducing inflammation.

PCOS is a complex disorder managed by treating symptoms and requires a team of specialists.

Taking riboflavin and eating less lysine can help some people with a specific genetic disorder avoid brain damage.

Toxic Epidermal Necrolysis is a rare, serious skin condition that can affect anyone, is more common in women, and may be linked to genetics, with a 20% mortality rate mainly due to sepsis.

Platelet-rich plasma (PRP) is a safe and potentially effective way to treat hair loss, especially when combined with minoxidil.